Form 4: Accenture GC Joel Unruch Receives Anti-Dilution RSU Grant

Accenture's General Counsel, Joel Unruch, was granted 48 Class A ordinary shares as Restricted Share Units on August 15, 2025, to offset dilution from a cash dividend.

Summary

• Joel Unruch, General Counsel and Corporate Secretary of Accenture plc, acquired 48 Class A ordinary shares.
• The transaction occurred on August 15, 2025, at a price of $247.57 per share.
• This acquisition was a grant of Restricted Share Units (RSUs) under anti-dilution provisions of existing RSU awards.
• The grant reflects Accenture plc's payment of a cash dividend, ensuring the value of previously granted RSUs is maintained.
• Following this transaction, Joel Unruch directly beneficially owns 17,699 Class A ordinary shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned transaction.

Sentiment

Score: 6

Explanation: The transaction is a routine anti-dilution RSU grant, which is a neutral to slightly positive event for the executive as it preserves the value of their existing equity. It reflects standard corporate governance and compensation practices.

Positives

• The grant of RSUs maintains the value of previously awarded equity for a key executive, Joel Unruch, due to anti-dilution provisions, aligning executive interests with long-term shareholder value.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned and automated transaction, which can reduce concerns about opportunistic insider trading.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation and anti-dilution provisions. Such grants are common practice in publicly traded companies to ensure executive equity awards maintain their value following corporate actions like dividend payments. It does not provide broader industry context.

Comparison to Industry Standards

• This is a standard anti-dilution RSU grant, a common practice across industries for executive compensation.
• Companies like IBM, Deloitte, and Capgemini, which are competitors in the consulting and IT services sector, also utilize similar equity compensation structures and anti-dilution mechanisms to retain and incentivize key personnel.
• The specific grant amount and price are tied to Accenture's stock performance and dividend policy, aligning with typical market practices for maintaining the value of outstanding equity awards.

Corporate Governance

Related Party Transactions

• The transaction involves an executive (Joel Unruch) and the company (Accenture plc), which is a standard insider transaction reported on Form 4. It is not a related party transaction in the sense of unusual dealings with entities outside the direct employee-company relationship.

Stakeholder Impact

• Shareholders: The anti-dilution grant ensures that the value of executive equity awards is maintained, which can be seen as a positive for executive retention and alignment with long-term shareholder interests. The transaction itself is a routine part of compensation.
• Employees: The transaction is specific to a senior executive's compensation and does not directly impact the broader employee base, though it reflects the company's overall compensation philosophy for equity awards.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider transaction (an anti-dilution RSU grant) for a key executive. It is not indicative of significant new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. It merely reflects standard executive compensation practices and the preservation of existing equity value.

Keywords

Accenture, ACN, Joel Unruch, Form 4, Insider Transaction, Restricted Share Units, RSU Grant, Anti-Dilution, Dividend, Executive Compensation, Corporate Governance